SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-14-408083
Filing Date
2014-11-12
Accepted
2014-11-12 09:07:00
Documents
9
Period of Report
2014-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d819654d6k.htm 6-K 11717
2 EX-99.1 d819654dex991.htm EX-99.1 9838
3 EX-99.2 d819654dex992.htm EX-99.2 404538
4 EX-99.3 d819654dex993.htm EX-99.3 133603
5 EX-99.4 d819654dex994.htm EX-99.4 9446
6 EX-99.5 d819654dex995.htm EX-99.5 9452
7 GRAPHIC g819654g08q84.jpg GRAPHIC 1198
8 GRAPHIC g819654g78a16.jpg GRAPHIC 2024
9 GRAPHIC g819654g93v02.jpg GRAPHIC 2935
  Complete submission text file 0001193125-14-408083.txt   588525
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 141211550
SIC: 2834 Pharmaceutical Preparations